Sheppard, Mullin, Richter & Hampton LLP

Sheppard, Mullin, Richter & Hampton LLP advises pharma, biotech, medical device, and digital health clients in matters spanning the entire product lifecycle. With notable FDA regulatory expertise, its work includes counseling, compliance, and due diligence matters. On the IP side, it handles strategic portfolio development and licensing, prosecution, and due diligence. The team is led by New York-based Jeffrey Fessler and Scott Liebman, who focus on corporate transactions and FDA regulatory, compliance, and legal matters, respectively. Jaime Choi joined San Diego’s Del Mar office from Snell & Wilmer LLP, bringing complex patent and disputes expertise. Washington DC-based Kwan-Ho Chung, who arrived from Perkins Coie LLP, focuses on patent prosecution, counseling, and litigation.